Clinical trials sponsored by Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine

Phase breakdown

Conditions studied

Recruiting trials led by Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine

• A Clinical Study of Sorafenib Combined With Gefitinib for the Treatment of pNET
  NCT06592989 · Phase: Not specified · Ages: 18 Years to 80 Years · Sex: All (male and female) · 1 location
• A Real-World Study Evaluating the Efficacy and Safety of Adebrelimab in Patients With Advanced SCLC
  NCT07434518 · Phase: Not specified · Ages: 18 Years to 100 Years · Sex: All (male and female) · 1 location
• Bile Omics for Diagnosing Indeterminate Biliary Strictures
  NCT07007832 · Phase: Not specified · Ages: 18 Years to 90 Years · Sex: All (male and female) · 1 location
• Cadonilimab Combined With S-1 or Capecitabine as Second-line Treatment for Advanced Pancreatic Cancer
  NCT06532617 · Phase: Phase 2 · Ages: 18 Years to 80 Years · Sex: All (male and female) · 1 location
• Clinical Study of Lewis Antigen Assay Combined With CA19-9 Assay to Assess Prognosis in Patients With Pancreatic Cancer
  NCT06515587 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Clinical Study of Multimodal Ablation Remodeling Immunosensitized PD-1 in the Treatment of Pancreatic Cancer With Liver Metastasis
  NCT06307080 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 70 Years · Sex: All (male and female) · 1 location
• Exploration of Treatment Effect of Novel Hormone Therapy Combined With Local Treatment Based on PSMA PET/CT Evaluation in mHSCP Patients
  NCT06832774 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · 1 location
• PGHD-AI Intelligent Model for the Nutritional Assessment and Intervention of Patients After Radical Surgery for Pancreatic Cancer.
  NCT07167264 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 80 Years · Sex: All (male and female) · 1 location
• Repetitive Transcranial Magnetic Stimulation(rTMS) Regulating Slow-wave to Delay the Progression of Parkinson's Disease
  NCT06002581 · Phase: Not applicable (e.g. observational or device study) · Ages: 50 Years to 80 Years · Sex: All (male and female) · 1 location
• Subthalamic Nucleus-Targeted Transcranial Temporal Interference Stimulation for Motor and Non-Motor Symptoms in Parkinson's Disease
  NCT07625540 · Phase: Not applicable (e.g. observational or device study) · Ages: 50 Years to 85 Years · Sex: All (male and female) · 1 location

Common questions

How many trials is Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine recruiting for?

Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine is the lead sponsor of 10 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.